SSC
AVNS

Syverson Strege & Co’s Avanos Medical AVNS Stock Holding History

Syverson Strege & Co’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-29
Closed -$862 – 103
2023
Q1 		$862 Hold
29
– – ﹤0.01% 613
2022
Q4 		$785 Hold
29
– – ﹤0.01% 282
2022
Q3 		$1K Hold
29
– – ﹤0.01% 259
2022
Q2 		$1K Hold
29
– – ﹤0.01% 305
2022
Q1 		$1K Hold
29
– – ﹤0.01% 280
2021
Q4 		$1K Hold
29
– – ﹤0.01% 279
2021
Q3 		$1K Hold
29
– – ﹤0.01% 423
2021
Q2 		$1K Hold
29
– – ﹤0.01% 254
2021
Q1 		$1K Hold
29
– – ﹤0.01% 247
2020
Q4 		$1K Buy
+29
New +$1.21K ﹤0.01% 227

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Syverson Strege & Co's AVNS Position: Q2 2023 in Review

Syverson Strege & Co sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 29 shares — an estimated $862 sold.

Syverson Strege & Co first reported a position in AVNS in Q4 2020 and held it in 10 quarters. The position peaked at $1K in Q3 2022. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.

  • Syverson Strege & Co reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
  • Syverson Strege & Co sold 29 Avanos Medical shares in Q2 2023, an estimated $862.
  • Syverson Strege & Co first reported a position in Avanos Medical in Q4 2020 and held it in 10 quarters.
  • Syverson Strege & Co's Avanos Medical position peaked at $1K in Q3 2022.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.

Based on Syverson Strege & Co's 13F filing for Q2 2023, filed 4 Aug 2023.